Variation in the Effect of Sex Hormones in Hidradenitis Suppurativa
On-Demand Video
Event Details
Skin of Color Society 21st Annual Skin of Color Society Scientific Symposium
Innovating for Equity
Presented and recorded on March 6, 2025 in Orlando, FL
This meeting was planned and organized by the 2024-2025 SOCS Scientific Committee co-chaired by Drs. Crystal Aguh and Cesar Antonio Virgen, MD, PhD, FAAD. View Final Program.
Tarannum Jaleel, MD, MHSc, FAAD
Assistant Professor, Duke Department of Dermatology
Director, Duke Dermatology Sponsored Clinical Trials Education
Dr. Jaleel received a Bachelor of Science in Biophysics from University of Alabama in Birmingham in 2007. After graduation, she worked with the European Institute of Women’s Health as a Fulbright scholar. She received both her Medical Degree and completed her residency in dermatology from University of Alabama in Birmingham School of Medicine. She then joined on as faculty at Duke in 2016 and completed a Master’s in Health Sciences through Duke’s Clinical Research Training Program.
Dr. Jaleel’s research focuses on studying the role of sex hormones in skin inflammation as it relates to hidradenitis suppurativa (HS) disease pathogenesis. Her early work on this topic has been funded by the Dermatology Foundation, Skin of Color Society, and Duke School of Medicine Precision Genomics Collaboratory Fostering Interdisciplinary Genomic Science pilot grant. Her most recent awards include the BIRCWH K12 grant and Physician-Scientist Strong Start Award that will allow for understanding the mechanisms by which hormone signaling modulates skin inflammation with the future goal of identifying novel therapeutic targets.
Her interests also include developing tools to decrease disparities in health outcomes and promoting diversity in dermatology clinical trials. She serves as the SOCS co-chair for the SOCS-NMA Diversity in Dermatology Clinical Trials Mentorship Program and is also the primary director for Duke Skin of Color Fellowship program.